SCHEMBL1969554

SCHEMBL1969554

N[C@@H](CSSCCNCc1ccccc1)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
EPHX1 P07099 1/20 0.47
MAOA P21397 2/20 0.43
ANPEP P15144 2/20 0.42
CHRM2 P08172 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42
SIGMAR1 Q99720 3/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
DRD4 P21917 1/20 0.38
MMP2 P08253 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL989960 0.82 EPHX1 (0.70) EPHX1MAOAANPEPSIGMAR1MMP2
SCHEMBL10005631 0.82 EPHX1 (0.70) EPHX1MAOAANPEPSIGMAR1MMP2
SCHEMBL11370850 0.82 MEN1 (0.70) MEN1KMT2ATDP1MAOACHRM2
SCHEMBL7247384 0.74 MAOA (0.58) MEN1KMT2ATDP1EPHX1MAOA
SCHEMBL17710346 0.74 MEN1 (0.59) MEN1KMT2ATDP1EPHX1MAOA
SCHEMBL421960 0.73 EPHX1 (0.61) MEN1KMT2ATDP1EPHX1MAOA
SCHEMBL421959 0.73 EPHX1 (0.61) MEN1KMT2ATDP1EPHX1MAOA
SCHEMBL17424040 0.72 MAOA (0.65) MEN1KMT2ATDP1EPHX1MAOA
SCHEMBL11121889 0.72 EPHX1 (0.59) MEN1KMT2ATDP1EPHX1MAOA
SCHEMBL23791770 0.71 MEN1 (0.64) MEN1KMT2ATDP1MAOACHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334651-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS Theravance, Inc. (US) 2011-06-22 EP disclosed
WO-2010011821-A2 DUAL-ACTING ANTIHYPERTENSIVE AGENTS THERAVANCE, INC. (US) 2010-01-28 WO disclosed